Latest news with #Celanese
Yahoo
07-07-2025
- Business
- Yahoo
Celanese to Hold Second Quarter Earnings Conference Call on August 12, 2025
DALLAS, July 07, 2025--(BUSINESS WIRE)--Celanese Corporation (NYSE: CE), a global chemical and specialty materials company, today announced that it will host a conference call to discuss its second quarter 2025 results on Tuesday, August 12, 2025, beginning at 9:00 a.m. ET. The conference call will be available by webcast at or by phone: Dial-in Number: 1-877-407-0989International Dial-In Number: 1-201-389-0921 Alternatively, to enter the call immediately without waiting for operator assistance, attendees may pre-register for the call by clicking the link below. Registrant Link: The company will distribute its second quarter earnings press release via newswire after the New York Stock Exchange closes on Monday, August 11, 2025. The earnings press release and prepared remarks will also be available at after market close on Monday, August 11, 2025. A replay of the conference call will be available on demand on August 12, 2025, from 11:00 a.m. ET until August 26, 2025, 11:00 a.m. ET, at the following number: Replay Number: 1-877-660-6853Passcode: 6966220 The webcast replay will be available on demand at About Celanese Celanese is a global leader in chemistry, producing specialty material solutions used across most major industries and consumer applications. Our businesses use our chemistry, technology and commercial expertise to create value for our customers, employees and shareholders. We support sustainability by responsibly managing the materials we create and growing our portfolio of sustainable products to meet customer and societal demand. We strive to make a positive impact in our communities and to foster inclusivity across our teams. Celanese Corporation is a Fortune 500 company with more than 11,000 employees worldwide and 2024 net sales of $10.3 billion. View source version on Contacts Celanese Contacts: Investor Relations Bill Cunningham+1 972 443 Media Relations – Global Kent Sholars+1 972 443 4400media@ Media Relations Europe (Germany) Petra Czugler+49 69 45009 Fehler beim Abrufen der Daten Melden Sie sich an, um Ihr Portfolio aufzurufen. Fehler beim Abrufen der Daten Fehler beim Abrufen der Daten Fehler beim Abrufen der Daten Fehler beim Abrufen der Daten
Business Wire
07-07-2025
- Business
- Business Wire
Celanese to Hold Second Quarter Earnings Conference Call on August 12, 2025
DALLAS--(BUSINESS WIRE)--Celanese Corporation (NYSE: CE), a global chemical and specialty materials company, today announced that it will host a conference call to discuss its second quarter 2025 results on Tuesday, August 12, 2025, beginning at 9:00 a.m. ET. The conference call will be available by webcast at or by phone: Dial-in Number: 1-877-407-0989 International Dial-In Number: 1-201-389-0921 Alternatively, to enter the call immediately without waiting for operator assistance, attendees may pre-register for the call by clicking the link below. Registrant Link: The company will distribute its second quarter earnings press release via newswire after the New York Stock Exchange closes on Monday, August 11, 2025. The earnings press release and prepared remarks will also be available at after market close on Monday, August 11, 2025. A replay of the conference call will be available on demand on August 12, 2025, from 11:00 a.m. ET until August 26, 2025, 11:00 a.m. ET, at the following number: Replay Number: 1-877-660-6853 Passcode: 6966220 The webcast replay will be available on demand at About Celanese Celanese is a global leader in chemistry, producing specialty material solutions used across most major industries and consumer applications. Our businesses use our chemistry, technology and commercial expertise to create value for our customers, employees and shareholders. We support sustainability by responsibly managing the materials we create and growing our portfolio of sustainable products to meet customer and societal demand. We strive to make a positive impact in our communities and to foster inclusivity across our teams. Celanese Corporation is a Fortune 500 company with more than 11,000 employees worldwide and 2024 net sales of $10.3 billion.
Yahoo
27-06-2025
- Business
- Yahoo
Glaukos gains EU certification for iStent infinite and other MIGS devices
Glaukos has secured European Union Medical Device Regulation (EU-MDR) certification for its iStent infinite, along with other micro-invasive glaucoma surgery (MIGS) technologies, including the iStent inject W. According to the company, its iStent trabecular micro-bypass stenting platform predominantly involves the insertion of micro-scale surgical devices intended to minimise intraocular pressure (IOP) with the restoration of pathways of the natural aqueous humor outflow for individuals with glaucoma. Known for creating two patent bypass pathways via the trabecular meshwork, the iStent inject W claims to be one of the smallest medical devices to be implanted in the body of a human. Its design allows for multi-directional flow through Schlemm's canal, offering a micro-invasive approach to glaucoma treatment. The iStent infinite Trabecular Micro-Bypass System Model iS3 is intended to minimise IOP in adults with primary open-angle glaucoma where prior treatments have failed. As the first standalone micro-invasive implantable alternative, the iStent infinite is said to have been tailored to maximise outflow with minimal disruption to natural anatomy, occupying 3% of Schlemm's canal. Glaukos CEO and chairman Thomas Burns said: "We are pleased to receive these important regulatory clearances for our leading trabecular micro-bypass stenting devices, marking our company's first approvals under the new EU regulatory framework. 'These important milestones will not only help us maintain and grow our presence in Europe but also advance and accelerate our broader Interventional Glaucoma initiatives globally. We are eager to commence commercial launch activities for these novel MIGS therapies over the coming months." Last year, the company began commercial launch activities for iDose TR, an intracameral procedural pharmaceutical that provides continuous glaucoma drug therapy inside the eye for extended periods. In 2023, speciality materials and chemical company Celanese entered an agreement with Glaukos for the supply of its VitalDose drug delivery platform. "Glaukos gains EU certification for iStent infinite and other MIGS devices" was originally created and published by Medical Device Network, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
Yahoo
24-06-2025
- Business
- Yahoo
Celanese Corporation (CE): A Bull Case Theory
We came across a bullish thesis on Celanese Corporation (CE) on Hidden Market Gems' Substack. In this article, we will summarize the bulls' thesis on CE. Celanese Corporation (CE)'s share was trading at $58.19 as of 11th of June. CE's trailing and forward P/E were 7.36 and 12.03 respectively according to Yahoo Finance. A close-up of a technician's hands pouring polymer powder into a metal mold. Celanese Corporation, long known for its adaptability in the chemical sector, presents a striking investment case as it emerges from a difficult 2024 marked by declining revenue, negative net income, and falling EBITDA. Despite these headwinds, the company beat expectations in Q1, and the broader picture reveals a company poised for recovery. With 2024 revenue at $10.28 billion and a net loss of $1.52 billion, the market has priced in much of the recent pain. Yet, forward-looking projections suggest that Celanese's future hinges on how well it navigates the evolving global energy landscape and executes within it. The most optimistic path shows a sharp rebound by 2029, potentially driven by strategic vertical consolidation and growth in high-margin specialty chemical segments. Celanese remains well-positioned due to strong end-market demand and a reputation for operational excellence. While 2024 margins have contracted significantly, long-term tailwinds like electrification, lightweight materials, and global industrial investment favor Celanese's core businesses. The company's ability to consolidate within its existing verticals could be transformative, especially if it aligns with favorable macro trends. Execution remains key, but the upside in a recovery scenario is significant, with the potential for material earnings and valuation improvement. For investors with a medium-term horizon, the current stock price reflects a margin of safety, offering an appealing risk/reward setup. In short, Celanese is an under-the-radar industrial play, currently bruised but fundamentally strong, and capable of meaningful rerating if it delivers on execution. We previously highlighted a on Celanese (CE) by Kyler Johnson, focusing on its post-M&M acquisition deleveraging path and cost discipline. Hidden Market Gems echoes this optimism but emphasizes CE's vertical consolidation potential and end-market tailwinds. Both see meaningful upside, with Johnson spotlighting FCF recovery and Hidden Market Gems highlighting long-term industrial transformation. Celanese Corporation (CE) is not on our list of the 30 Most Popular Stocks Among Hedge Funds. As per our database, 41 hedge fund portfolios held CE at the end of the first quarter which was 35 in the previous quarter. While we acknowledge the risk and potential of CE as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock. Disclosure: None. This article was originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
04-06-2025
- Business
- Yahoo
Celanese (CE) Up 9.6% Since Last Earnings Report: Can It Continue?
It has been about a month since the last earnings report for Celanese (CE). Shares have added about 9.6% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading up to its next earnings release, or is Celanese due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important drivers. It turns out, fresh estimates have trended downward during the past month. At this time, Celanese has a subpar Growth Score of D, though it is lagging a bit on the Momentum Score front with an F. However, the stock was allocated a grade of B on the value side, putting it in the second quintile for this investment strategy. Overall, the stock has an aggregate VGM Score of D. If you aren't focused on one strategy, this score is the one you should be interested in. Estimates have been broadly trending downward for the stock, and the magnitude of these revisions indicates a downward shift. Notably, Celanese has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months. Celanese is part of the Zacks Chemical - Specialty industry. Over the past month, Element Solutions (ESI), a stock from the same industry, has gained 3.3%. The company reported its results for the quarter ended March 2025 more than a month ago. Element Solutions reported revenues of $593.7 million in the last reported quarter, representing a year-over-year change of +3.3%. EPS of $0.34 for the same period compares with $0.34 a year ago. Element Solutions is expected to post earnings of $0.33 per share for the current quarter, representing a year-over-year change of -8.3%. Over the last 30 days, the Zacks Consensus Estimate has changed -0.5%. Element Solutions has a Zacks Rank #3 (Hold) based on the overall direction and magnitude of estimate revisions. Additionally, the stock has a VGM Score of D. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Celanese Corporation (CE) : Free Stock Analysis Report Element Solutions Inc. (ESI) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research
